Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -21.12 | 16.43 |
PEG Ratio (TTM) | 0.33 | 2.14 |
P/S Ratio (TTM) | 10.18 | 1.69 |
P/B Ratio (TTM) | 11.62 | 3.05 |
P/FCF Ratio (TTM) | -3.50 | 10.49 |
Price to 5YR AVG Earnings Ratio | N/A | 2.72 |
Price to 5YR AVG FCF Ratio | N/A | 33.37 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -7.75% | 7.46% |
ROE (TTM) | -30.25% | 17.51% |
Net Profit Margin (TTM) | -48.18% | 9.15% |
ROIC 5YR AVG | N/A | 6.21% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -92.68% | N/A | N/A |
Revenue | 26.91% | N/A | N/A |
Net Income | -117.64% | N/A | N/A |
Cash Flow | -11.36% | N/A | N/A |
Health (23%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.73 | 1.84 |
Quick Ratio (TTM) | 0.73 | 1.33 |
D/E Ratio (TTM) | 2.86 | 1.07 |
Interest Coverage (TTM) | -0.17 | 16.78 |
Piotroski F-Score | 6 | 7 |
Altman Z-Score | 2.53 | 2.92 |
LTL to 5YR AVG FCF | N/A | 8.37 |
Shares Outstanding Growth 5YR AVG | N/A | 6.51% |